TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that pursuant to an agreement entered in 2018, it assisted Rubicon Private Limited (Rubicon) with the establishment of a commercial platform that allowed it to launch its first products in the US market on a label held by its affiliate, Advagen Pharma Ltd. (Advagen).